The Klarman Cell Observatory Scientific Advisory Board
The members of the Klarman Cell Observatory (KCO) Scientific Advisory Board meet annually to review the KCO's progress over the past year and provide advice on future scientific directions to the KCO.
Geneviève Almouzni, Ph.D.
Director, Institut Curie Research Center
Naama Barkai, Ph.D.
Professor, Weizmann Institute of Science
Elaine Fuchs, Ph.D.
Rebecca C. Lancefield Professor, Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, Rockefeller University
Investigator, Howard Hughes Medical Center
Levi Garraway, M.D., Ph.D.
Senior Vice President, Global Development and Medical Affairs, Eli Lilly and Company
Diane Mathis, Ph.D.
Professor, Harvard Medical School
Director, JDRF Center on Immunological Tolerance in Type-1 Diabetes
Jill Mesirov, Ph.D.
Associate Vice Chancellor for Computational Health Sciences and Professor of Medicine, University of California, San Diego School of Medicine and Moores Cancer Center
Phillip A. Sharp, Ph.D.
Institute Professor, MIT
Kevin Struhl, Ph.D.
David Wesley Gaiser Professor of Biological Chemistry, Harvard Medical School
Jonathan S. Weissman, Ph.D.
Professor, University of California at San Francisco
Investigator, Howard Hughes Medical Institute